Shareholding4 Jul 2026, 11:30 am
Gujarat Themis Biosyn: Indirect Encumbrance on 47.02% Shares
AI Summary
Gujarat Themis Biosyn Limited (GTBL) has reported an indirect encumbrance on 47.02% of its equity share capital, amounting to 5,12,40,000 shares. This arises from a pledge of 51% and a non-disposal undertaking of 47.98% of the shares in Pharmaceutical Business Group (India) Limited (PBGIL) by Vividhmargi Investments Private Limited (VIPL) in favor of CTL Trusteeship Limited. PBGIL is a promoter group entity holding a significant stake in GTBL. The disclosure was made on July 3, 2026, as per SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Indirect encumbrance created on 47.02% of GTBL shares.
- Pledge and non-disposal undertaking on shares of PBGIL by VIPL.
- CTL Trusteeship Limited is the beneficiary of the encumbrance.
- Disclosure made under SEBI (SAST) Regulations, 2011.
Price Impact
More from GUJTHEM